• Latest
  • Trending
  • All
  • Sport
  • Cricket
  • Odisha
covaxin children trial

COVID-19 Mutant Strain Threat Prompted Covaxin’s Approval, Say Minutes Of SEC Meetings

5 years ago
Oplus_131072

Missing Tripura Girl’s Body Found In Yamuna River In Delhi

6 hours ago
Ben Stokes clean bowled

Lord’s Test: Sundar Spell Leaves India Victory Target Of 196; England Pacers Hit Back With 4 Late Wickets

7 hours ago
Indore helmet man

Why Does ‘Helmet Man’ Roam Indore Streets With Camera On Head? Watch Viral Video

8 hours ago
Oplus_131072

India Is Still ‘Saare Jahan Se Achha’: Gp Cpt Shubhanshu Shukla In Farewell Message From ISS

8 hours ago

35-Minute Meeting Between CM Majhi & PM Modi In New Delhi!

8 hours ago
Dalai Lama

Tibet-Related Issues ‘Thorn’ In Ties With India, Says China Ahead Of Jaishankar’s Visit

8 hours ago

Food Infection Not Diarrhoea, Ravenshaw Issues Statement After Hospitalisation Of 27 Hostel Boarders

9 hours ago
Arrested in berhampur plot scam

Mastermind Of Multi-Crore Residential Plot Scam Arrested In Odisha’s Berhampur

9 hours ago

Another Couple Tied To Yoke Like Bullocks For Marrying Within Same Clan In Odisha

9 hours ago
Oplus_131072

Tipra Motha Demands ‘Bihar Model’ Of Voter Roll Revision For Tripura And Other Northeastern States

10 hours ago
Vidyutprabha Devi’s 100th Birth Anniversary

‘True Symbol Of Women’s Empowerment’: Vidyutprabha Devi’s 100th Birth Anniversary Celebrated At Ramadevi University

10 hours ago

Why Did Odisha Student Attempt Self-Immolation? Father Narrates Her Ordeal

10 hours ago
  • Home
  • About us
  • Career
  • Contact
  • Privacy Policy
Monday, July 14, 2025
No Result
View All Result
Odisha Bytes
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review
Odisha Bytes
No Result
View All Result
Home Virus Scare Coronavirus

COVID-19 Mutant Strain Threat Prompted Covaxin’s Approval, Say Minutes Of SEC Meetings

by OB Bureau
January 6, 2021
in Coronavirus, Featured, India
Reading Time: 1 min read
covaxin children trial

Picture courtesy The News Minute

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

New Delhi: The impending danger of the new mutant strain of coronavirus found in the UK helped Bharat Biotech get  emergency use approval for its vaccine candidate Covaxin. India has now reported 71 cases of mutant strain with number rising each day.

The Subject Expert Committee (SEC) meeting of the Central Drugs Standard Control Organisation (CDSCO), however, showed it changed its stance regarding Bharat Biotech’s vaccine candidate.

In three meetings, SEC changed its decision from insisting on efficacy data to approving Covaxin under the ‘clinical trial mode’ sans the Phase 3 clinical trials data, reported India Today.

According to the minutes, SEC insisted on efficacy data between December 30 and January 1. On January 1, 2021, the same SEC asked Bharat Biotech to expedite the hiring process and furnish interim efficacy data.

However, it approved emergency use authorisation to Covaxin on January 2 under the mysterious ‘clinical trial mode’.

“In light of the recommendations of the committee dated 01.01.2021, the firm further presented the updated data, justification and requested for consideration of their proposal in the wake of incidence of new mutated coronavirus infection. As already noted by the committee, this vaccine is Inactivated Whole Virion, coronavirus vaccine having the potential to target mutated coronavirus strains,” said minutes of the SEC meeting on January 2 as quoted by India Today.

However, minutes of the December 30 meeting quoted the SEC as saying, “After detailed deliberation, the committee recommended that the firm should update and present immunogenicity, safety and efficacy data for further consideration.”

ALSO READ: Bharat Biotech To Produce Data To Show Covaxin’s Efficacy On Mutant Strain

Tags: approvalcovaxinCOVID-19MinutesMutant StrainSEC MeetingsThreat
Share196Tweet123

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
OB Bureau

OB Bureau

Odisha Bytes

Copyright © 2025 Frontier Media

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

No Result
View All Result
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review

Copyright © 2025 Frontier Media